• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index

    12/11/20 8:05:00 PM ET
    $TTWO
    $TEAM
    $AEP
    $PTON
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $TTWO alert in real time by email

    NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX), which will become effective prior to market open on Monday, December 21, 2020.

    The following six companies will be added to the Index: American Electric Power Company, Inc. (Nasdaq: AEP), Marvell Technology Group Ltd. (Nasdaq: MRVL), Match Group, Inc. (Nasdaq: MTCH), Okta, Inc. (Nasdaq: OKTA), Peloton Interactive, Inc. (Nasdaq: PTON), Atlassian Corporation Plc (Nasdaq: TEAM).

    The Nasdaq-100 Index is composed of the 100 largest non-financial companies listed on The Nasdaq Stock Market® and dates to January 1985 when it was launched along with the Nasdaq Financial-100 Index®, which is comprised of the 100 largest financial stocks on Nasdaq®. These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100 is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index is the basis of the Invesco QQQ Trust (Nasdaq: QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index performance. In addition, options, futures and structured products based on the Nasdaq-100 Index and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following six companies will be removed from the Index: BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), Citrix Systems, Inc. (Nasdaq: CTXS), Expedia Group, Inc. (Nasdaq: EXPE), Liberty Global plc (Nasdaq: LBTYA/LBTYK), Take-Two Interactive Software, Inc. (Nasdaq: TTWO), Ulta Beauty, Inc. (Nasdaq: ULTA).

    Information
    For information about the six companies to be added to the Nasdaq-100 Index, please visit the following respective company websites:

    American Electric Power Company, Inc. – https://www.aep.com/

    Marvell Technology Group Ltd. – https://www.marvell.com/

    Match Group, Inc. – https://www.mtch.com/

    Okta, Inc. – https://www.okta.com/

    Peloton Interactive, Inc. – https://www.onepeloton.com/

    Atlassian Corporation Plc – https://www.atlassian.com/

    About Nasdaq Global Indexes
    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index and design solutions to financial organizations worldwide.

    About Nasdaq
    Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

    Media Relations Contact
    Emily Pan
    (646) 637-3964
    [email protected]

    Issuer & Investor Contact
    Index Client Services
    [email protected]

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    -NDAQG-


    Get the next $TTWO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TTWO
    $TEAM
    $AEP
    $PTON

    CompanyDatePrice TargetRatingAnalyst
    BioMarin Pharmaceutical Inc.
    $BMRN
    9/8/2025$60.00Neutral
    H.C. Wainwright
    Ulta Beauty Inc.
    $ULTA
    9/4/2025$590.00Overweight
    Piper Sandler
    BioMarin Pharmaceutical Inc.
    $BMRN
    9/3/2025$85.00Outperform
    Raymond James
    Marvell Technology Inc.
    $MRVL
    8/29/2025$78.00Buy → Neutral
    BofA Securities
    Ulta Beauty Inc.
    $ULTA
    8/29/2025$590.00 → $610.00Outperform
    Telsey Advisory Group
    Marvell Technology Inc.
    $MRVL
    8/29/2025$85.00 → $80.00Buy
    Needham
    Okta Inc.
    $OKTA
    8/27/2025$132.00 → $112.00Market Perform
    BMO Capital Markets
    Okta Inc.
    $OKTA
    8/26/2025$120.00Hold → Buy
    Canaccord Genuity
    More analyst ratings

    $TTWO
    $TEAM
    $AEP
    $PTON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on BioMarin Pharmaceutical with a new price target

    H.C. Wainwright initiated coverage of BioMarin Pharmaceutical with a rating of Neutral and set a new price target of $60.00

    9/8/25 8:48:48 AM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Piper Sandler resumed coverage on Ulta Beauty with a new price target

    Piper Sandler resumed coverage of Ulta Beauty with a rating of Overweight and set a new price target of $590.00

    9/4/25 9:08:30 AM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    Raymond James initiated coverage on BioMarin Pharmaceutical with a new price target

    Raymond James initiated coverage of BioMarin Pharmaceutical with a rating of Outperform and set a new price target of $85.00

    9/3/25 8:29:10 AM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TTWO
    $TEAM
    $AEP
    $PTON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting

    Children who received VOXZOGO showed anatomical improvements in spinal morphology VOXZOGO continued to significantly improve growth in children who received the medicine after puberty onset SAN RAFAEL, Calif., Sept. 8, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced new data from 14 studies were presented at the American Society for Bone and Mineral Research 2025 (ASBMR) Annual Meeting in Seattle, including results demonstrating treatment with VOXZOGO® (vosoritide) led to anatomical improvements in spinal morphology in young children, and continued efficacy in children who received the medicine after the onset of puberty.

    9/8/25 9:00:00 AM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BioMarin Announces Positive Pivotal Phase 3 Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria at 15th International Congress of Inborn Errors of Metabolism

    New data from Phase 3 PEGASUS study demonstrates a 49.7% decrease in mean blood Phe levels in adolescents aged 12-17 treated with PALYNZIQ BioMarin's planned submission to global health authorities on track for second half of 2025 SAN RAFAEL, Calif., Sept. 6, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced new data characterizing the efficacy and safety of PALYNZIQ® (pegvaliase-pqpz) for the treatment of adolescents with phenylketonuria (PKU), which were presented at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) in Kyoto, Japan, Sept. 2-6, 2025.

    9/6/25 11:05:00 AM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nasdaq CFO Sarah Youngwood to Present at Barclays Annual Global Financial Services Conference

    NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.com. Who:      Sarah Youngwood, Executive Vice President & CFO, Nasdaq   What: Barclays 23rd Annual Global Financial Services Conference   When: Monday, September 8th, 2025, 9:00 AM ET    About NasdaqNasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that impro

    9/4/25 4:05:00 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $TTWO
    $TEAM
    $AEP
    $PTON
    SEC Filings

    View All

    Atlassian Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Atlassian Corp (0001650372) (Filer)

    9/8/25 5:26:28 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEFA14A filed by Invesco QQQ Trust, Series 1

    DEFA14A - INVESCO QQQ TRUST, SERIES 1 (0001067839) (Filer)

    9/8/25 5:01:24 PM ET
    $QQQ

    SEC Form 8-K filed by Take-Two Interactive Software Inc.

    8-K - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Filer)

    9/5/25 4:35:26 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $TTWO
    $TEAM
    $AEP
    $PTON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    $TTWO
    $TEAM
    $AEP
    $PTON
    Leadership Updates

    Live Leadership Updates

    View All

    $TTWO
    $TEAM
    $AEP
    $PTON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    June 29, 2023 - FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

    For Immediate Release: June 29, 2023 Today, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy for the treatment of adults with severe hemophilia A without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test. “Hereditary hemophilia A is a potentially serious bleeding disorder. Severe cases of hemophilia A can ca

    6/29/23 6:02:12 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Atlassian Enters Into Definitive Agreement to Acquire The Browser Company of New York

    Atlassian and The Browser Company to join forces to build the AI browser for knowledge workers Atlassian Corporation (NASDAQ:TEAM), a leading provider of team collaboration and productivity software, today announced it has entered into a definitive agreement to acquire The Browser Company, the company behind the Dia and Arc browsers. Together, the companies intend to deliver the browser for knowledge work in the AI era. Today's browsers were built before the explosion of SaaS apps, and well before the current AI revolution. Optimized to appeal to the consumer masses, browsers were not designed for the knowledge workers who rely on them to get things done. For these workers, each tab con

    9/4/25 8:05:00 AM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Participation from Fortum Innovation & Venturing to strengthen its supplier infrastructure

    HELSINKI, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Puro.earth, a leading carbon-crediting platform for engineered carbon dioxide removal (CDR), today announced it has raised €11 million in a Series B funding round led by Nasdaq with participation from Fortum Innovation & Venturing. Puro.earth will deploy this funding to strengthen the infrastructure that supports its best-in-class certification journey for suppliers. Key initiatives include enabling more frequent issuance of high-integrity carbon removal credits, facilitating offtake agreements, and advancing open integration of digital measurement, reporting, and verification (dMRV) tools. The new investment builds on a period of strong gr

    9/4/25 7:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Ulta Beauty Appoints Martin Brok and Stephenie Landry to Its Board of Directors

    Ulta Beauty, Inc. (NASDAQ:ULTA) today announced the appointments of Martin Brok and Stephenie Landry to its Board of Directors and as members of its Audit and Compensation Committees, effective September 1, 2025. "We're thrilled to welcome Martin and Stephenie to our Board of Directors," said Kecia Steelman, President & Chief Executive Officer. "Martin is an accomplished, strategic leader with deep international experience in the areas of retailing, merchandising, and brand strategy, while Stephenie has strong operational and digital innovation expertise and sustainability leadership. Their transformative track records and strategic vision will be invaluable as we navigate our next chapte

    8/21/25 9:00:00 AM ET
    $OTLY
    $ULTA
    Packaged Foods
    Consumer Staples
    Other Specialty Stores
    Consumer Discretionary

    Director Belsky Scott bought $251,715 worth of shares (1,455 units at $173.00) (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    8/29/25 7:06:50 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Rascoff Spencer M bought $497,861 worth of shares (13,250 units at $37.57), increasing direct ownership by 10% to 150,728 units (SEC Form 4)

    4 - Match Group, Inc. (0000891103) (Issuer)

    8/28/25 4:14:17 PM ET
    $MTCH
    Computer Software: Programming Data Processing
    Technology

    Chief Executive Officer Rascoff Spencer M bought $1,988,247 worth of shares (70,885 units at $28.05), increasing direct ownership by 106% to 137,478 units (SEC Form 4)

    4 - Match Group, Inc. (0000891103) (Issuer)

    5/12/25 9:00:01 AM ET
    $MTCH
    Computer Software: Programming Data Processing
    Technology

    $TTWO
    $TEAM
    $AEP
    $PTON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Kirol Charles Peter sold $71,752 worth of shares (8,969 units at $8.00), decreasing direct ownership by 28% to 23,321 units (SEC Form 4)

    4 - PELOTON INTERACTIVE, INC. (0001639825) (Issuer)

    9/8/25 5:03:18 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Director Smith Mike C. sold $264,215 worth of shares (500 units at $528.43), decreasing direct ownership by 18% to 2,263 units (SEC Form 4)

    4 - Ulta Beauty, Inc. (0001403568) (Issuer)

    9/8/25 4:53:06 PM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    CEO, Co-Founder Cannon-Brookes Michael sold $1,317,648 worth of shares (7,665 units at $171.90) (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    9/8/25 4:23:50 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    $TTWO
    $TEAM
    $AEP
    $PTON
    Financials

    Live finance-specific insights

    View All

    Marvell Technology, Inc. Reports Second Quarter of Fiscal Year 2026 Financial Results

    Q2 Net Revenue: $2.006 billion, a new record, grew by 58% year-on-yearQ2 Gross Margin: 50.4% GAAP gross margin; 59.4% non-GAAP gross marginQ2 Diluted income per share: $0.22 GAAP diluted income per share; $0.67 non-GAAP diluted income per shareFinancial outlook for the third quarter of fiscal 2026 reflects the divestiture of Marvell's Automotive Ethernet business on August 14, 2025SANTA CLARA, Calif., Aug. 28, 2025 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ:MRVL), a leader in data infrastructure semiconductor solutions, today reported financial results for the second quarter of fiscal year 2026. Net revenue for the second quarter of fiscal 2026 was $2.006 billion, $6.0 million above th

    8/28/25 4:05:00 PM ET
    $MRVL
    Semiconductors
    Technology

    Ulta Beauty Announces Second Quarter Fiscal 2025 Results

    Net Sales Increased 9.3% to $2.8 Billion Compared to $2.6 Billion in the Prior Year Quarter Comparable Sales Increased 6.7% Net Income Increased to $260.9 Million or $5.78 Per Diluted Share Ulta Beauty, Inc. (NASDAQ:ULTA) today announced financial results for the thirteen-week period ("second quarter") and twenty-six-week period ("first six months") ended August 2, 2025, compared to the same periods ended August 3, 2024.     13 Weeks Ended   26 Weeks Ended     August 2,   August 3,   August 2,   August 3, (Dollars in millions, except per share data) 2025 (1)   2024  

    8/28/25 4:05:00 PM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    Ulta Beauty to Report Second Quarter Fiscal 2025 Results on August 28, 2025

    Ulta Beauty, Inc. (NASDAQ:ULTA) today announced that its financial results for the second quarter of fiscal year 2025 will be released Thursday, August 28, 2025, after the market closes. The Company will host a webcast and conference call at 4:30 p.m. ET / 3:30 p.m. CT to discuss the financial results. Information about Ulta Beauty's financial results, including a link to the live webcast, will be available on the Company's Investor Relations website at https://www.ulta.com/investor. There will also be an archived webcast available for a limited time thereafter. Please register for the live event at https://q2-2025-ulta-beauty-earnings-conference-call.open-exchange.net/. About Ulta Be

    8/15/25 9:00:00 AM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    $TTWO
    $TEAM
    $AEP
    $PTON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Atlassian Corporation

    SC 13G/A - Atlassian Corp (0001650372) (Subject)

    11/14/24 1:22:40 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Peloton Interactive Inc.

    SC 13G/A - PELOTON INTERACTIVE, INC. (0001639825) (Subject)

    11/14/24 1:22:39 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Peloton Interactive Inc.

    SC 13G/A - PELOTON INTERACTIVE, INC. (0001639825) (Subject)

    11/13/24 12:52:42 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary